Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and May 2018

Showing 1 to 10 of 385
Title Reference number Published Last updated
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy Reference number:TA520 TA00520 Published:May 2018 20180501 Last updated:May 2018 20180516
Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy Reference number:TA519 TA00519 Published:April 2018 20180401 Last updated:April 2018 20180425
Tocilizumab for treating giant cell arteritis Reference number:TA518 TA00518 Published:April 2018 20180401 Last updated:April 2018 20180418
Avelumab for treating metastatic Merkel cell carcinoma Reference number:TA517 TA00517 Published:April 2018 20180401 Last updated:April 2018 20180411
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen Reference number:TA515 TA00515 Published:March 2018 20180301 Last updated:March 2018 20180328
Cabozantinib for treating medullary thyroid cancer Reference number:TA516 TA00516 Published:March 2018 20180301 Last updated:March 2018 20180328
Brodalumab for treating moderate to severe plaque psoriasis Reference number:TA511 TA00511 Published:March 2018 20180301 Last updated:March 2018 20180321
Tivozanib for treating advanced renal cell carcinoma Reference number:TA512 TA00512 Published:March 2018 20180301 Last updated:March 2018 20180321
Obinutuzumab for untreated advanced follicular lymphoma Reference number:TA513 TA00513 Published:March 2018 20180301 Last updated:March 2018 20180321
Regorafenib for previously treated advanced hepatocellular carcinoma Reference number:TA514 TA00514 Published:March 2018 20180301 Last updated:March 2018 20180321